Quifenadine

Quifenadine
Clinical data
Trade names	Fencarol
Other names	3-Quinuclidinyldiphenylmethanol
Routes of; administration	Oral (tablets), IM injection
ATC code	R06AX31 (WHO) ;
Legal status
Legal status	OTC (tablets), Rx-only (solution for IM injection) (RU);
Pharmacokinetic data
Bioavailability	45% (Tmax = 1 hour)
Metabolism	Liver
Identifiers
	IUPAC name 1-Azabicyclo[2.2.2]octan-3-yl(diphenyl)methanol;
CAS Number	10447-39-9 ; HCl: 10447-38-8 ;
PubChem CID	65600;
ChemSpider	59041;
UNII	W9A18RJ49B; HCl: 6WSK4828LL ;
KEGG	D10230;
ChEMBL	ChEMBL1187694;
CompTox Dashboard (EPA)	DTXSID6046187 ;
Chemical and physical data
Formula	C20H23NO
Molar mass	293.410 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(c1ccccc1)(c2ccccc2)C4C3CCN(CC3)C4;
	InChI InChI=1S/C20H23NO/c22-20(17-7-3-1-4-8-17,18-9-5-2-6-10-18)19-15-21-13-11-16(19)12-14-21/h1-10,16,19,22H,11-15H2; Key:PZMAHNDJABQWGS-UHFFFAOYSA-N;

Quifenadine (‹The template Lang-rus is being considered for deletion.› Russian: хифенадин, trade name: Phencarol, Фенкарол) is a 2nd generation antihistamine drug, marketed mainly in post-Soviet countries.^[2]^[3] Chemically, it is a quinuclidine derivative.

Quick Facts Clinical data, Trade names ...

Close

The drug has antiarrhythmic properties, probably due to the presence of a quinuclidine nucleus in the molecule's core. It acts as a calcium channel blocker and influences the activity of potassium channels.^{[clarification needed]} In children with cardiac arrhythmia, combination therapy with quifenadone and either amiodarone or propafenone was found to be more effective than monotherapy with either amiodarone or propafenone.^[4]

Quifenadine is a derivative of quinuclidylcarbinol, which reduces the effects of histamine on organs and systems. Quifenadine is a competitive blocker of H1 receptors. In addition, it activates the diamine oxidase enzyme, which breaks down about 30% of endogenous histamine. This explains the effectiveness of quifenadine in patients insensitive to other antihistamines. The antihistaminic qualities of quifenadine are associated with the presence of a cyclic quinuclidine core in the structure and the distance between the diphenylcarbinol group and the nitrogen atom. In terms of antihistaminic activity and duration of action, quifenadine is superior to diphenhydramine. Quifenadine reduces the toxic effect of histamine, eliminates or weakens its bronchoconstrictor effect and spasmodic effect on the smooth muscles of the intestines, has a moderate antiserotonin and weak cholinolytic effect, has well-defined antipruritic and desensitizing properties. Quifenadine weakens the hypotensive effect of histamine and its effect on capillary permeability, does not directly affect cardiac activity and blood pressure, does not have a protective effect in aconitine arrhythmias.^[5]

[2]

[3]

[1]

[4]

[5]

Quifenadine

Indications

Synthesis

See also

References

Wikiwand - on